Financials
- Market Capitalization 429.37 M
- Employee 350
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.31
売上高対価格比率
1.44
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2896 | TLRY Tilray Brands, Inc. - Common Stock | 4.46 USD | +0.90% | +0.45% | -12.20% | +565.67% | 519.81 M USD | ||
| 2911 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.06 USD | -1.46% | -5.80% | -3.56% | +0.50% | 509.33 M USD | ||
| 3064 | KMDA Kamada Ltd. - Ordinary Shares | 7.17 USD | +0.70% | -3.76% | -4.14% | -8.66% | 413.61 M USD | ||
| 3065 | EBS Emergent BioSolutions Inc. Common Stock | 8.01 USD | -0.25% | -2.91% | -4.30% | -25.28% | 413.29 M USD |